Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer

Phanes Therapeutics reports clinical data on spevatamig chemotherapy combination in frontline treatment of mPDAC

Acousia Therapeutics completes patient enrolment in Phase 2 trial of Bimokalner

ZYUS Life Sciences reports positive preliminary results from Phase 2a trial of Trichomylin softgel

DELFI Diagnostics names new chief financial officer

Arbele's ARB1002 receives US FDA Orphan Drug Designation

GSK reports positive phase III results for bepirovirsen in chronic hepatitis B

Day One completes Mersana acquisition to add rare cancer antibody drug conjugate

Cartography Biosciences partners with Pfizer to discover tumour-selective antigens

BostonGene and AstraZeneca collaborate to advance AI-driven oncology development

RedHill advances RHB-102 across GI indications

Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China

BioInvent reports encouraging Phase 2a data for BI-1808 plus pembrolizumab in recurrent ovarian cancer

Hoth Therapeutics files two US provisional patent applications to establish oncology-focused dermatology platform

Insilico Medicine signs multi-year research and development collaboration with Servier